These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9154410)

  • 1. Influence of pH on the antimicrobial activity of clarithromycin and 14-hydroxyclarithromycin against Haemophilus influenzae using an in vitro pharmacodynamic model.
    Garrison MW; Malone CL; Eiland J; Anderson DE
    Diagn Microbiol Infect Dis; 1997 Apr; 27(4):139-45. PubMed ID: 9154410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of antimicrobial activities of clarithromycin and 14-hydroxyclarithromycin against three strains of Haemophilus influenzae by using an in vitro pharmacodynamic model.
    Walker KJ; Larsson AJ; Zabinski RA; Rotschafer JC
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2003-7. PubMed ID: 7811010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A time-kill evaluation of clarithromycin and azithromycin against two extracellular pathogens and the development of resistance.
    Burgess DS; Hastings RW; Horan JL
    Ann Pharmacother; 1999 Dec; 33(12):1262-5. PubMed ID: 10630825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of antibiotic-resistant Streptococcus pneumoniae and beta-lactamase-positive Haemophilus influenzae in clinical isolates from patients with otitis media.
    McLinn S; Williams D
    Pediatr Infect Dis J; 1996 Sep; 15(9 Suppl):S3-9. PubMed ID: 8878239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bactericidal activity and postantibiotic effect of clarithromycin and 14-hydroxyclarithromycin, alone and in combination, against Legionella pneumophila.
    Martin SJ; Pendland SL
    J Antimicrob Chemother; 1998 Jun; 41(6):643-8. PubMed ID: 9687103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clarithromycin in vitro activity enhanced by its major metabolite, 14-hydroxyclarithromycin.
    Hoover WW; Barrett MS; Jones RN
    Diagn Microbiol Infect Dis; 1992; 15(3):259-66. PubMed ID: 1533827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penetration of clarithromycin and its 14-hydroxy metabolite into middle ear effusion in children with secretory otitis media.
    Sundberg L; Cederberg A
    J Antimicrob Chemother; 1994 Feb; 33(2):299-307. PubMed ID: 8182011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of the in vitro and in vivo activities of clarithromycin against Haemophilus influenzae by 14-hydroxy-clarithromycin, its major metabolite in humans.
    Hardy DJ; Swanson RN; Rode RA; Marsh K; Shipkowitz NL; Clement JJ
    Antimicrob Agents Chemother; 1990 Jul; 34(7):1407-13. PubMed ID: 2143642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Streptococcus pneumoniae and Haemophilus influenzae in the development of acute otitis media and otitis media with effusion in a gerbil model.
    Soriano F; Parra A; Cenjor C; Nieto E; García-Calvo G; Giménez MJ; Aguilar L; Ponte C
    J Infect Dis; 2000 Feb; 181(2):646-52. PubMed ID: 10669350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penetration of clarithromycin into middle ear fluid of children with acute otitis media.
    Gan VN; McCarty JM; Chu SY; Carr R
    Pediatr Infect Dis J; 1997 Jan; 16(1):39-43. PubMed ID: 9002099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicentre in-vitro evaluation of the susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis to ciprofloxacin, clarithromycin, co-amoxiclav and sparfloxacin.
    Hoogkamp-Korstanje JA; Dirks-Go SI; Kabel P; Manson WL; Stobberingh EE; Vreede RW; Davies BI
    J Antimicrob Chemother; 1997 Mar; 39(3):411-4. PubMed ID: 9096192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probability of achieving requisite pharmacodynamic exposure for oral beta-lactam regimens against Haemophilus influenzae in children.
    Pichichero ME; Doern GV; Kuti JL; Nicolau DP
    Paediatr Drugs; 2008; 10(6):391-7. PubMed ID: 18998749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. The Laboratory Investigator Group.
    Thornsberry C; Ogilvie P; Kahn J; Mauriz Y
    Diagn Microbiol Infect Dis; 1997 Dec; 29(4):249-57. PubMed ID: 9458982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility testing of Haemophilus influenzae to clarithromycin.
    Paton R; Arnold J; Cockburn J; Emmanuel FX
    J Antimicrob Chemother; 2000 Apr; 45(4):529-31. PubMed ID: 10747833
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Chan CL; Richter K; Wormald PJ; Psaltis AJ; Vreugde S
    Front Cell Infect Microbiol; 2017; 7():344. PubMed ID: 28824879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The activity of clarithromycin and its 14-hydroxy metabolite against Haemophilus influenzae, determined by in-vitro and serum bactericidal tests.
    Dabernat H; Delmas C; Seguy M; Fourtillan JB; Girault J; Lareng MB
    J Antimicrob Chemother; 1991 Feb; 27 Suppl A():19-30. PubMed ID: 1827099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kill kinetics of antimicrobial agents against Helicobacter pylori.
    Flamm RK; Beyer J; Tanaka SK; Clement J
    J Antimicrob Chemother; 1996 Oct; 38(4):719-25. PubMed ID: 8937967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility patterns for amoxicillin/clavulanate tests mimicking the licensed formulations and pharmacokinetic relationships: do the MIC obtained with 2:1 ratio testing accurately reflect activity against beta-lactamase-producing strains of Haemophilus influenzae and Moraxella catarrhalis?
    Pottumarthy S; Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2005 Nov; 53(3):225-31. PubMed ID: 16257168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effect of thiamphenicol glycinate, thiamphenicol glycinate N-acetylcysteinate, amoxicillin plus clavulanic acid, ceftriaxone and clarithromycin on pulmonary clearance of Haemophilus influenzae in an animal model.
    Drago L; Fassina MC; Mombelli B; De Vecchi E; Lombardi A; Gismondo MR
    Chemotherapy; 2000; 46(4):275-81. PubMed ID: 10859433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using antibiotic concentrations in middle ear fluid to predict potential clinical efficacy.
    Harrison CJ
    Pediatr Infect Dis J; 1997 Feb; 16(2 Suppl):S12-6. PubMed ID: 9041622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.